Literature DB >> 15842373

Plasma von Willebrand factor and arterial aging.

U M Vischer, F R Herrmann, T Peyrard, R Nzietchueng, A Benetos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15842373     DOI： 10.1111/j.1538-7836.2005.01242.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  7 in total

1.  Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.

Authors:  S Albánez; K Ogiwara; A Michels; W Hopman; J Grabell; P James; D Lillicrap
Journal:  J Thromb Haemost       Date:  2016-04-27       Impact factor: 5.824

Review 2.  Current and Emerging Options for the Management of Inherited von Willebrand Disease.

Authors:  Jessica M Heijdra; Marjon H Cnossen; Frank W G Leebeek
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

Review 3.  The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy.

Authors:  Felice Gragnano; Simona Sperlongano; Enrica Golia; Francesco Natale; Renatomaria Bianchi; Mario Crisci; Fabio Fimiani; Ivana Pariggiano; Vincenzo Diana; Andreina Carbone; Arturo Cesaro; Claudia Concilio; Giuseppe Limongelli; Mariagiovanna Russo; Paolo Calabrò
Journal:  Mediators Inflamm       Date:  2017-05-28       Impact factor: 4.711

4.  Von Willebrand factor (vWF) in patients with heart failure with preserved ejection fraction (HFpEF): A retrospective observational study.

Authors:  Mayila Abudoukelimu; Bayinsilema Ba; Yan Kai Guo; Jie Xu
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

5.  Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis and Low Cardiovascular Risk: The Role of von Willebrand Factor Activity.

Authors:  Gorica G Ristić; Vesna Subota; Toplica Lepić; Dejana Stanisavljević; Branislava Glišić; Arsen D Ristić; Milan Petronijević; Dušan Z Stefanović
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

6.  Isolation, characterization, and transplantation of cardiac endothelial cells.

Authors:  Busadee Pratumvinit; Kanit Reesukumal; Kajohnkiart Janebodin; Nicholas Ieronimakis; Morayma Reyes
Journal:  Biomed Res Int       Date:  2013-10-27       Impact factor: 3.411

7.  Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease.

Authors:  Ferdows Atiq; Karina Meijer; Jeroen Eikenboom; Karin Fijnvandraat; Eveline P Mauser-Bunschoten; Karin P M van Galen; Marten R Nijziel; Paula F Ypma; Joke de Meris; Britta A P Laros-van Gorkom; Johanna G van der Bom; Moniek P de Maat; Marjon H Cnossen; Frank W G Leebeek
Journal:  Br J Haematol       Date:  2018-05-16       Impact factor: 6.998
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.